InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: 1oldprof post# 327074

Wednesday, 10/07/2020 8:46:19 AM

Wednesday, October 07, 2020 8:46:19 AM

Post# of 403078
My shift was just finished, thank you. I notice you have no rebuttal for my supposed disinformation, other than to say it might work.

I said many times that B v C might work. It might.

And it might not. You have already stated the obvious: lab data may or may not translate into actual patients.

The homework is not mine to do. The RBL has done homework on someone's suggestion- DeGrado's? And from what we know- very little indeed-B has antiviral activity. We have no specifics because we have no data yet, except a few conclusions provided by IP.

My guess is that there is no difference in our views at this point: the trial is what matters. Other than you have more of a stake in the game, a lot more shares.

I would be happy to have DeGrado as Person of the Year and B as Synthetic Molecule of the Century if all goes well, and we can meet back here in 4-6 months if IP can get things moving
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News